Company profile for Epygenix Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs that treat Dravet syndrome (DS) and other genetic epilepsies. DS is a rare and catastrophic form of intractable epilepsy that begins in infancy. Current therapeutic options are not effective, and the constant care required can severely impact quality of life for the entire family. Dravet syndrome, like most...
Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs that treat Dravet syndrome (DS) and other genetic epilepsies. DS is a rare and catastrophic form of intractable epilepsy that begins in infancy. Current therapeutic options are not effective, and the constant care required can severely impact quality of life for the entire family. Dravet syndrome, like most genetic forms of epilepsy, represents an orphan indication with an unmet medical need.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
140 E. Ridgewood Ave. Suite 415, South Tower Paramus, NJ 07652
Telephone
Telephone
1 (201) 940-7377
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/harmony-biosciences-acquires-epygenix-therapeutics-inc-adding-late-stage-epilepsy-franchise-to-growing-pipeline-of-innovative-cns-assets-302131000.html

PR NEWSWIRE
30 Apr 2024

https://www.pharmiweb.com/press-release/2022-07-21/epygenix-therapeutics-to-participate-in-rw-bairds-biotech-discovery-series

PHARMIWEB
21 Jul 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-03-15/epygenix-therapeutics-names-darren-cline-as-president-and-ceo/?widget=listSection

CONTRACTPHARMA
15 Mar 2022

https://www.prnewswire.com/news-releases/epygenix-therapeutics-announces-fda-acceptance-of-ind-to-initiate-a-clinical-trial-of-epx-100-to-treat-lennox-gastaut-syndrome-301364855.html

PRNEWSWIRE
30 Aug 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=140525&sid=2

PHARMABIZ
02 Aug 2021

https://www.prnewswire.com/news-releases/epygenix-therapeutics-announces-first-patient-successfully-dosed-in-phase-2-study-for-the-treatment-of-dravet-syndrome-with-epx-100-301171444.html

PRNEWSWIRE
12 Nov 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty